< Back to latest news & events

Event

Medilink UK Brexit Webinar (Intellectual Property)

October 2019

Event date: 14th October 2019

HGF Patent Attorney Dr Frazer Bye is hosting Medilink UK webinar on the IP implications of Brexit on 14th October at 10am.

The government maintains that the UK will leave the EU on 31 October 2019, with or without a deal in place. This, therefore, leaves businesses with many questions on how they might be affected and what can be done to prepare.

Medilink UK is working with the Department for Business, Energy and Industrial Strategy (BEIS) to provide crucial advice and guidance. In the meantime, HGF Patent Attorney Dr Frazer Bye is hosting a webinar, where he will cover the main aspects of what to expect after the Brexit deadline. HGF Senior Trade Mark Attorney Jennifer Good will also be joining the webinar to answer all trade mark related questions.

The webinar will cover the following:

  • How IP rules might change after Brexit
  • Guidance for IP professionals
  • The effect of no-deal on EU patents, trade marks, designs and the exhaustion of rights, including importing and exporting
  • Risks and opportunities that Brexit presents for businesses.

Latest updates

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting of …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article